Alerts will be sent to your verified email
Verify Email
MARKSANS
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Marksans Pharma is an Indian pharmaceutical company with a global presence, excelling in research, manufacturing, and marketing of finished dosage pharmaceutical formulations. Their focus areas include a wide range of OTC & prescription drugs across various fields.
Marksans Pharma major competitors are Procter&Gamble Healt, FDC, Strides Pharma Scien, Caplin Point Lab, Jubilant Pharmova, Sanofi India, Unichem Lab.
Market Cap of Marksans Pharma is ₹9,727 Crs.
While the median market cap of its peers are ₹8,713 Crs.
Marksans Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | Mar Jun Sep | Mar Jun Sep | Jun Dec | Jun | Mar | Sep Dec | Jun Sep | ||||||||
| Investor Presentation | Feb | Feb Mar Jun Sep Dec | Mar Jun Sep Dec | Feb Mar May Jun Aug Sep Nov Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | |||||||||||
| Conference Call | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep | Dec | |||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
